Literature DB >> 24423079

Jaundice in resected pancreatic cancer patients.

Fenja M Feld1, Jochen K Lennerz.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24423079      PMCID： PMC3921017          DOI： 10.1111/hpb.12158

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  4 in total

1.  Absence of FLICE-inhibitory protein is a novel independent prognostic marker for very short survival in pancreatic ductal adenocarcinoma.

Authors:  Sandra J Schmid; Marie-Charlotte Glatzel; Claudia Welke; Marko Kornmann; Alexander Kleger; Thomas F E Barth; Simone Fulda; Jochen K Lennerz; Peter Möller
Journal:  Pancreas       Date:  2013-10       Impact factor: 3.327

2.  Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.

Authors:  Steven M Strasberg; Feng Gao; Dominic Sanford; David C Linehan; William G Hawkins; Ryan Fields; Danielle H Carpenter; Elizabeth M Brunt; Carolyn Phillips
Journal:  HPB (Oxford)       Date:  2013-04-22       Impact factor: 3.647

3.  Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma.

Authors:  Sung Ryol Lee; Hyung Ook Kim; Byung Ho Son; Chang Hak Yoo; Jun Ho Shin
Journal:  Hepatogastroenterology       Date:  2013 Mar-Apr

4.  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

Authors:  Jaekyoung Son; Costas A Lyssiotis; Haoqiang Ying; Xiaoxu Wang; Sujun Hua; Matteo Ligorio; Rushika M Perera; Cristina R Ferrone; Edouard Mullarky; Ng Shyh-Chang; Ya'an Kang; Jason B Fleming; Nabeel Bardeesy; John M Asara; Marcia C Haigis; Ronald A DePinho; Lewis C Cantley; Alec C Kimmelman
Journal:  Nature       Date:  2013-03-27       Impact factor: 49.962
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.